Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1992 Jul;83(7):775–782. doi: 10.1111/j.1349-7006.1992.tb01979.x

Antitumor Effect of PSK at a Distant Site: Tumor‐specific Immunity and Combination with Other Chemotherapeutic Agents

Takusaburo Ebina 1,, Kazuko Murata 1
PMCID: PMC5918941  PMID: 1517151

Abstract

The antitumor effect of PSK, a Coriolus preparation, was analyzed with the double grafted tumor system in which BALB/c mice received intradermal inoculations of syngeneic Meth‐A fibrosarcoma in the right (primary tumor, 105 cells) and left (distant tumor, 2 × 105 cells) flanks. Intratumoral administration of PSK significantly inhibited the growth of not only the right but also the left tumor. PSK also inhibited the growth of a methylcholanthrene‐induced fibrosarcoma BAMC‐1, and a methylurethane‐induced adenocarcinoma Colon 26 in the double grafted tumor system of syngeneic BALB/c mice. However, when the left distant tumor was different from the right Meth‐A tumor, the intratumoral administration of PSK in the right tumor was unable to inhibit the growth of the left’ BAMC‐1 or RL♂ ‐1 tumor. The PSK‐induced immunity, therefore, is tumor‐specific and T lymphocytes may play an important role in antitumor memory function. The enhancement of concomitant immunity by PSK treatment was completely impaired by previous intravenous administration of an alkylating agent, cyclophosphamide (CY). The enhancement of sinecomitant immunity by PSK treatment was also impaired by previous CY intravenous administration. The antitumor effect of PSK was suppressed by previous intravenous administration of another alkylating agent, ACNU. It is possible that alkylating agents suppress the function of effector T cells and granulocytes which are very important for the antitumor immune cascade reaction due to PSK treatment. On the other hand, the antitumor effect of PSK was enhanced by previous intravenous administration of an anti‐metabolite, 5‐fluorouraeil.

Keywords: Key words, BRM, Combination therapy, Cyclophosphamide, Tumor specificity, Antagonistic effect

Full Text

The Full Text of this article is available as a PDF (391.9 KB).

REFERENCES

  • 1. ) Ebina , T. , Kohya , H. , Yamaguchi , T. and Ishida , N.Antimetastatic effect of biological response modifiers in the “double grafted tumor system.” Jpn. J. Cancer Res. , 77 , 1034 – 1042 ( 1986. ). [PubMed] [Google Scholar]
  • 2. ) Ebina , T. and Kohya , H.Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein‐bound polysaccharide preparation . Jpn. J. Cancer Res. , 19 , 957 – 964 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Ebina , T. , Kohya , H. and Ishikawa , K.Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse . Jpn. J. Cancer Res. , 80 , 158 – 166 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. ) Ebina , T. and Ishikawa , K.Antitumor effect of inter‐leukin‐1β in the double grafted tumor system . Jpn. J. Cancer Res. , 80 , 570 – 576 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Kohya , H. , Ebina , T. , Yamaguchi , T. and Ishida , N.The “double grafted tumor system,” proposed to find effector cells in the analyses of antitumor effect of BRMs . Bio-therapy , 1 , 139 – 151 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Ebina , T. and Murata , K.Antitumor effect of PSK at a distant site: inductions of interleukin‐8‐like factor and macrophage chemotactic factor in murine tumor . Jpn. J. Cancer Res. , 81 , 1307 – 1313 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. ) Ebina , T. and Murata , K.Antitumor effector mechanism of interleukin‐1β at a distant site in the double grafted tumor system . Jpn. J. Cancer Res. , 82 , 1292 – 1298 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. ) Saito , M. , Ichimura , O. , Kataoka , M. , Moriya , Y. , Ueno , K. , Sugawara , Y. , Nanjo , M. and Ishida , N.Pronounced antitumor effect of LAK‐like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK‐432, a killed Streptococcal preparation . Cancer Immunol. Immunother. , 22 , 161 – 168 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Kohya , H. , Ishii , F. , Takano , S. , Katori , T. , Ebina , T. and Ishida , N.Antitumor effect of a synthetic cord factor, 6,6′‐di‐O‐decanoyl‐α, α‐trehalose (SS554), in mice . Jpn. J. Cancer Res. , 77 , 602 – 609 ( 1986. ). [PubMed] [Google Scholar]
  • 10. ) Nakajima , I. and Chu , T. M.Synergistic antitumor activity of interleukin‐2 and cimetidine against syngeneic murine tumor . Cancer Immunol. Immunother. , 33 , 9 – 14 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. ) Rollinghoff , M. , Starzinski‐Powitz , A. , Pfizenmaier , K. and Wagner , H.Cyclophosphamide‐sensitive T lymphocytes suppress the in vivo generation of antigen‐specific cytotoxic T lymphocytes . J. Exp. Med. , 145 , 455 – 459 ( 1977. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) North , R. J.Cyclophosphamide‐facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor‐induced suppressor T cells . J. Exp. Med. , 155 , 1063 – 1074 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. ) Peppoloni , S. , Mathieson , B. J. , Gerberman , R. B. , Oveton , R. W. and Gorelik , E.In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets . Cancer Immunol. Immunother. , 24 , 49 – 56 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Cryz , S. J. , Furer , E. and Germanin , R.Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice . Infect. Immunol , 39 , 1067 – 1071 ( 1983. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Powderly , W. G. , Pier , G. B. and Markham , R. B.T lymphocyte‐mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice . J. Clin. Invest. , 78 , 375 – 380 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Gamba‐Vitalo , C. , GiGiovanna , M. P. and Sartorellik , A. C.Effects of recombinant murine granulocyte‐macro‐phage colony‐stimulating factor in cyclophosphamide‐treated mice . Blood Cells , 17 , 193 – 205 ( 1991. ). [PubMed] [Google Scholar]
  • 17. ) Nishimura , Y. , Mayumi , H. , Tomita , Y. , Eto , M. , Maeda , T. and Nomoto , K.Recombinant human granulocyte colony‐stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide‐induced tolerance system . J. Immunol , 146 , 2639 – 2647 ( 1991. ). [PubMed] [Google Scholar]
  • 18. ) Hirose , K. , Zachariae , C. O. C. , Oppenheim , J. J. and Matsushima , K.Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells . Lymphokine Res. , 9 , 475 – 483 ( 1990. ). [PubMed] [Google Scholar]
  • 19. ) Wadler , S. , Schwartz , E. L. , Goldman , M. , Lyverk , A. , Rader , M. , Zimmerman , M. , Itri , L. , Weinberg , V. and Wiernik , P. H.Fluorouracil and recombinant alfa‐2a‐interferon: an active regimen against advanced colorectal cancer . J. Clin. Oncol , 7 , 1769 – 1775 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Kemeny , N. , Younes , A. , Seiter , K. , Kelsen , D. , Sammarco , P. , Adams , L. , Derby , S. , Murray , P. and Houston , C.Interferon alpha‐2a and 5‐fluorouracil for advanced colorectal carcinoma . Cancer , 66 , 2470 – 2475 ( 1990. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES